A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ME3241 Administered Intravenously in Healthy Adult Participants

NCT07422207 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

104

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

BIOLOGICAL: ME3241
OTHER: Placebo

Sponsor

Meiji Pharma USA Inc.